Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Hepatitis A is an acute liver infection caused by the hepatitis A virus (HAV), primarily transmitted through contaminated food and water. As per Ammara Abdul Majeed et al. (2025), approximately 14 million cases occur globally. This viral hepatitis burden highlights the importance of prevention. According to hepatitis A epidemiology forecast by Expert Market Research, disease trends remain important for market assessment.
Base Year
Historical Period
Forecast Period

Read more about this report - Request a Free Sample
Expert Market Research's “Hepatitis A Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of hepatitis A. It projects the future incidence and prevalence rates of hepatitis A cases across various populations. The study covers age, gender, and type as major determinants of the hepatitis A population. The report highlights patterns in the prevalence of hepatitis A over time and projects future trends based on multiple variables.
The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of hepatitis A in the 8 major markets.
Regions Covered
Hepatitis A is a contagious liver infection caused by the hepatitis A virus (HAV), which is primarily transmitted through the ingestion of contaminated food or water or through close contact with an infected person. The infection causes liver inflammation and may result in fatigue, nausea, abdominal discomfort, dark urine, and jaundice. Unlike hepatitis B and C, hepatitis A does not cause chronic liver infection. Disease severity ranges from mild, self-limiting illness to severe, occasionally life-threatening complications, particularly among older adults and individuals with preexisting liver disease. Fecal-oral transmission is the principal route of infection.
|
Parameter |
Insight |
|
Largest Patient Pool |
India |
|
Fastest Growing Country |
India |
|
High-Risk Population |
Children in endemic settings, unvaccinated individuals, international travelers, and people with chronic liver disease |
|
Key Diagnostic Method |
Detection of immunoglobulin M antibodies against hepatitis A virus (anti-HAV IgM) in blood |
|
Major Risk Factor |
Consumption of food or water contaminated with the hepatitis A virus, particularly where sanitation and hygiene are inadequate |
|
Major gap in the market |
Unequal access to vaccination, limited awareness, and gaps in timely diagnosis and outbreak surveillance |
The hepatitis A epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the hepatitis A epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for hepatitis A and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.
|
Epidemiology Segment |
Key Insights |
|
Diagnosed Prevalent Cases of the Disease |
According to Ammara Abdul Majeed et al. (2025), hepatitis A affects tens of millions of people globally, with approximately 14 million cases and 28,000 deaths annually, highlighting its continuing public health burden across different settings. |
|
Gender-Specific Cases of the Disease |
According to Hyunjin Son et al. (2024), hepatitis A incidence has historically been higher among men, although gender patterns have changed, highlights the importance of monitoring sex-specific trends in disease surveillance. |
|
Age-Specific Cases of the Disease |
According to the Centers for Disease Control and Prevention, the highest reported hepatitis A rate in the United States in 2021 occurred among adults aged 30-39 years, at 3.9 cases per 100,000 population. |
|
Ethnicity-Wise Cases of the Disease |
According to Centers for Disease Control and Prevention, the hepatitis A case rate among Hispanic individuals in the United States in 2023 was 2.0 times the rate among non-Hispanic White individuals, indicating differences in the reported disease burden across ethnic populations. |
|
Mortality and Survival Analysis of the Disease |
According to Ammara Abdul Majeed et al. (2025), hepatitis A caused approximately 28,000 deaths annually worldwide, compared with 7,134 deaths reported in 2016. These estimates highlight the continuing contribution of hepatitis A to global mortality. |
|
Disease Type |
Prevalence and Epidemiology |
|
Genotype I |
One of the major human-infecting genotypes of hepatitis A virus, contributing to human infections across different regions. Its distribution is influenced by sanitation, food and water hygiene, and population immunity. |
|
Genotype II |
A human-infecting genotype associated with hepatitis A cases. Its contribution to the overall disease burden varies by geographic region, and molecular surveillance helps assess its distribution. |
|
Genotype III |
A major human-infecting genotype that contributes to the global burden of hepatitis A. Its prevalence varies geographically, with molecular surveillance supporting the identification of circulating strains. |
|
Genotypes IV, V, and VI |
These genotypes primarily infect nonhuman primates and do not account for the major share of human hepatitis A cases, which are primarily associated with genotypes I, II, and III. |

Read more about this report - Request a Free Sample
The hepatitis A epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.
|
Country |
Key Insights |
|
United States |
According to Centers for Disease Control and Prevention, the reported hepatitis A rate in the United States was 1.7 cases per 100,000 population in 2021, representing a 43% decrease from 2020. As per Centers for Disease Control and Prevention, 1,648 new cases and 85 hepatitis A-related deaths were reported in 2023, while estimated infections reached 3,300 after adjustments for underascertainment and underreporting. The case count declined by 28% between 2022 and 2023. Adults aged 30-39 years had the highest reported case rate in 2023. |
|
Germany |
Cross-border transmission, foodborne exposure, sanitation, population immunity, and outbreak surveillance can influence the occurrence and detection of hepatitis A cases in Germany. |
|
France |
According to Kazuteru Murakoshi et al. (2025), the average annual incidence of hepatitis A in France was 1.79 in the study's reported incidence measure during 2007-2021. Outbreaks were recorded in 2009 and 2017. Hepatitis A cases increased by 489% in 2017, potentially in association with the wider outbreak affecting men who have sex with men. Following the COVID-19 pandemic, reported cases decreased significantly. These findings highlight temporal fluctuations in disease occurrence and the importance of ongoing surveillance. |
|
Italy |
According to Angela Domínguez et al. (2025), Italy has an incidence of hepatitis A below the threshold of 5 cases per 100,000 inhabitants, similar to Spain and Portugal. This places Italy among settings with low reported incidence in the comparative information provided. Continued monitoring of reported cases and changes in exposure patterns remains relevant for understanding the national epidemiological profile. The supplied information does not provide a specific Italian annual case count, age distribution, or mortality estimate. |
|
Spain |
According to Angela Domínguez et al. (2025), Spain recorded a cumulative hepatitis A hospitalization incidence of 8.84 per million population over a 22-year period. The corresponding rates were 12.54 per million among men and 5.26 per million among women. The study also reported a hepatitis A incidence rate below 5 per 100,000 inhabitants. According to the same authors, seroprevalence among individuals aged 30-39 years was 22.94% in 2017-2018. Hospitalization outcomes varied by age and underlying health conditions. |
|
United Kingdom |
Hepatitis A epidemiology in the United Kingdom can be assessed through reported cases, age-specific incidence, outbreak surveillance, and population immunity. Monitoring changes in case distribution can help identify shifts in transmission patterns and inform public health responses. Comparisons with other countries should consider differences in surveillance methods, reporting practices, and the periods covered by available estimates. The supplied information does not include a United Kingdom-specific incidence rate, prevalence estimate, annual case count, or mortality figure. |
|
Japan |
According to Kazuteru Murakoshi et al. (2025), Japan's average hepatitis A incidence was 0.21 in the study's reported incidence measure during 2007-2021. Outbreaks were recorded in 2010, 2014, and 2018, and cases increased by 324% in 2018. In 2014, 80.5% of cases were associated with contaminated seafood or water. According to European Medical Group Ltd., hepatitis A cases had decreased by 89.5% by 2021, while infections among individuals aged 70 years and older remained stable. |
|
India |
According to Beacon (2025), Kerala reported 31,536 confirmed and probable hepatitis A cases and 82 deaths as of December 30, 2025. The state recorded 28,412 cases and 96 deaths in 2024, compared with 4,581 cases and 15 deaths in 2023. The reported age distribution shifted toward adolescents and adults aged 20-40 years. These figures indicate sustained transmission in Kerala during 2024-2025. The supplied figures relate specifically to Kerala and should not be interpreted as national estimates for India. |
Hepatitis A epidemiology across the United States, Germany, France, Italy, Spain, the United Kingdom, Japan, and India varies with sanitation, vaccination coverage, population immunity, and exposure patterns. India presents opportunities to strengthen preventive vaccination strategies, improve access to safe water, and enhance outbreak surveillance. In the other countries, targeted vaccination for susceptible high-risk groups, improved awareness among international travelers, and timely identification of outbreaks remain important priorities. Strengthening laboratory diagnosis, public health reporting, and access to preventive interventions can help address regional gaps and reduce the disease burden.
There is no specific antiviral treatment for hepatitis A. Management primarily involves supportive care, including adequate rest, hydration, balanced nutrition, and symptom management. Patients should avoid alcohol and consult healthcare professionals before using medications that may affect liver function. Severe cases involving acute liver failure may require hospitalization and specialized medical care. Hepatitis A vaccination is an effective preventive measure, while post-exposure prophylaxis with a vaccine or immune globulin may be recommended for eligible individuals, depending on age, health status, and exposure timing. Supportive therapy remains the primary approach for uncomplicated infections.
Alcoholic Hepatitis Treatment Market
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
|
Report Features |
Details |
|
Base Year |
2025 |
|
Historical Period |
2019-2025 |
|
Forecast Period |
2026-2035 |
|
Epidemiology Statistics Provided |
|
|
Segmentation Provided |
|
|
Geographies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.